Allosteric regulation of glycogen synthase kinase 3β: a theoretical study
- PMID: 21105670
- PMCID: PMC3005830
- DOI: 10.1021/bi100822q
Allosteric regulation of glycogen synthase kinase 3β: a theoretical study
Abstract
Glycogen synthase kinase 3β (GSK-3β) is a serine-threonine kinase belonging to the CMGC family that plays a key role in many biological processes, such as glucose metabolism, cell cycle regulation, and proliferation. Like most protein kinases, GSK-3β is regulated via multiple pathways and sites. We performed all-atom molecular dynamics simulations on the unphosphorylated and phosphorylated unbound GSK-3β and the phosphorylated GSK-3β bound to a peptide substrate, its product, and a derived inhibitor. We found that GSK-3β autophosphorylation at residue Tyr(216) results in widening of the catalytic groove, thereby facilitating substrate access. In addition, we studied the interactions of the phosphorylated GSK-3β with a substrate and peptide inhibitor located at the active site and observed higher affinity of the inhibitor to the kinase. Furthermore, we detected a potential remote binding site which was previously identified in other kinases. In agreement with experiments we observed that binding of specific peptides at this remote site leads to stabilization of the activation loop located in the active site. We speculate that this stabilization could enhance the catalytic activity of the kinase. We point to this remote site as being structurally conserved and suggest that the allosteric phenomenon observed here may occur in the protein kinase superfamily.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3005830/bin/bi-2010-00822q_0001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3005830/bin/bi-2010-00822q_0002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3005830/bin/bi-2010-00822q_0003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3005830/bin/bi-2010-00822q_0004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3005830/bin/bi-2010-00822q_0005.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3005830/bin/bi-2010-00822q_0006.gif)
![Figure 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3005830/bin/bi-2010-00822q_0007.gif)
![Figure 8](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3005830/bin/bi-2010-00822q_0008.gif)
Similar articles
-
Elucidating substrate and inhibitor binding sites on the surface of GSK-3β and the refinement of a competitive inhibitor.J Mol Biol. 2011 Apr 29;408(2):366-78. doi: 10.1016/j.jmb.2011.02.036. Epub 2011 Feb 25. J Mol Biol. 2011. PMID: 21354422
-
Novel benzothiazinones (BTOs) as allosteric modulator or substrate competitive inhibitor of glycogen synthase kinase 3β (GSK-3β) with cellular activity of promoting glucose uptake.Bioorg Med Chem Lett. 2014 Dec 15;24(24):5639-5643. doi: 10.1016/j.bmcl.2014.10.078. Epub 2014 Oct 30. Bioorg Med Chem Lett. 2014. PMID: 25467150
-
Glycogen synthase kinase-3beta phosphorylation of MAP1B at Ser1260 and Thr1265 is spatially restricted to growing axons.J Cell Sci. 2005 Mar 1;118(Pt 5):993-1005. doi: 10.1242/jcs.01697. J Cell Sci. 2005. PMID: 15731007
-
Design of glycogen synthase kinase-3 inhibitors: an overview on recent advancements.Curr Pharm Des. 2013;19(26):4755-75. doi: 10.2174/1381612811319260007. Curr Pharm Des. 2013. PMID: 23260024 Review.
-
GSK-3β Allosteric Inhibition: A Dead End or a New Pharmacological Frontier?Int J Mol Sci. 2023 Apr 19;24(8):7541. doi: 10.3390/ijms24087541. Int J Mol Sci. 2023. PMID: 37108703 Free PMC article. Review.
Cited by
-
Understanding Glycogen Synthase Kinase-3: A Novel Avenue for Alzheimer's Disease.Mol Neurobiol. 2024 Jul;61(7):4203-4221. doi: 10.1007/s12035-023-03839-1. Epub 2023 Dec 8. Mol Neurobiol. 2024. PMID: 38064104 Review.
-
Crosstalk between GSK-3β-actuated molecular cascades and myocardial physiology.Heart Fail Rev. 2021 Nov;26(6):1495-1504. doi: 10.1007/s10741-020-09961-9. Heart Fail Rev. 2021. PMID: 32314086 Review.
-
Microsecond molecular dynamics simulations and dynamic network analysis provide understanding of the allosteric inactivation of GSK3β induced by the L343R mutation.J Mol Model. 2019 Apr 4;25(5):111. doi: 10.1007/s00894-019-4003-x. J Mol Model. 2019. PMID: 30949773
-
Regulation of platelet-activating factor-induced interleukin-8 expression by protein tyrosine phosphatase 1B.Cell Commun Signal. 2019 Mar 4;17(1):21. doi: 10.1186/s12964-019-0334-6. Cell Commun Signal. 2019. PMID: 30832675 Free PMC article.
-
Investigation of naphthofuran moiety as potential dual inhibitor against BACE-1 and GSK-3β: molecular dynamics simulations, binding energy, and network analysis to identify first-in-class dual inhibitors against Alzheimer's disease.J Mol Model. 2017 Aug;23(8):239. doi: 10.1007/s00894-017-3396-7. Epub 2017 Jul 24. J Mol Model. 2017. PMID: 28741112
References
-
- Grimes C. A.; Jope R. S. (2001) The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog. Neurobiol. 65, 391–426. - PubMed
-
- Shapira M.; Licht A.; Milman A.; Pick C. G.; Shohami E.; Eldar-Finkelman H. (2007) Role of glycogen synthase kinase-3beta in early depressive behavior induced by mild traumatic brain injury. Mol. Cell. Neurosci. 34, 571–577. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous